Metropolitan Life Insurance CO Oramed Pharmaceuticals Inc. Transaction History

Metropolitan Life Insurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.72 - $9.0 $7,361 - $17,811	-1,979 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$8.19 - $13.89 $16,208 - $27,488	1,979 New	1,979 $17,000
Q1 2022 Mar 30, 2023	SELL	$8.19 - $13.89 $52,473 - $88,993	-6,407 Reduced 76.4%	1,979 $17,000
Q1 2022 May 12, 2022	SELL	$8.19 - $13.89 $52,473 - $88,993	-6,407 Reduced 76.4%	1,979 $17,000
Q4 2021 Jun 21, 2023	BUY	$12.98 - $29.75 $108,850 - $249,483	8,386 New	8,386 $119,000
Q3 2021 Jun 21, 2023	BUY	$12.13 - $23.82 $101,722 - $199,754	8,386 New	8,386 $184,000
Q2 2021 Jun 21, 2023	BUY	$8.34 - $14.59 $69,939 - $122,351	8,386 New	8,386 $112,000
Q2 2021 Mar 30, 2023	BUY	$8.34 - $14.59 $69,939 - $122,351	8,386 New	8,386 $112,000
Q2 2021 Aug 16, 2021	BUY	$8.34 - $14.59 $69,939 - $122,351	8,386 New	8,386 $112,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.9M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.